STOCKHOLDERS’ EQUITY (Tables)
|
9 Months Ended |
Jan. 31, 2025 |
|---|
| Equity [Abstract] |
|
| SCHEDULE OF ACTIVITY RESTRICTED AND DEFERRED STOCK UNITS |
A
summary of the changes in RSUs and DSUs outstanding during the nine months ended January 31, 2025 follows:
SCHEDULE
OF ACTIVITY RESTRICTED AND DEFERRED STOCK UNITS
| |
|
Restricted and Deferred
Stock Units |
|
|
Weighted
Average
Grant-Date
Fair Value
Per Share |
|
| Balance at April 30, 2024 |
|
|
433,475 |
|
|
$ |
10.31 |
|
| Granted |
|
|
160,913 |
|
|
|
7.65 |
|
| Converted into common stock |
|
|
(7,927 |
) |
|
|
9.34 |
|
| Balance at January 31, 2025 |
|
|
586,461 |
|
|
$ |
9.60 |
|
|
| SCHEDULE OF STOCK OPTION ACTIVITY |
The
following is a summary of the Company’s stock option activity during the nine months ended January 31, 2025:
SCHEDULE
OF STOCK OPTION ACTIVITY
| |
|
Number of
Options
|
|
|
Weighted
Average
Exercise Price
|
|
|
Weighted
Average
Remaining
Contractual
Life (Years)
|
|
| Balance at April 30, 2024 |
|
|
192,750 |
|
|
$ |
5.54 |
|
|
|
3.44 |
|
| Granted |
|
|
293,730 |
|
|
|
7.65 |
|
|
|
5.00 |
|
| Exercised |
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Forfeited |
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Cancelled |
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Balance at January 31, 2025 |
|
|
486,480 |
|
|
|
6.81 |
|
|
|
3.97 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Options exercisable at end of period |
|
|
382,127 |
|
|
$ |
6.59 |
|
|
|
|
|
| Options expected to vest |
|
|
104,353 |
|
|
$ |
7.64 |
|
|
|
|
|
| Weighted average fair value of options granted during the period |
|
|
|
|
|
$ |
4.94 |
|
|
|
|
|
|
| SCHEDULE OF STOCK OPTION VALUATION ASSUMPTION |
SCHEDULE
OF STOCK OPTION VALUATION ASSUMPTION
| Risk-free interest rate |
|
|
4.17- 4.43 % |
|
| Dividend yield |
|
|
0.00 |
% |
| Expected volatility |
|
|
76-77 % |
|
| Contractual and expected term (in years) |
|
|
5.0 |
|
| Forfeiture rate |
|
|
0.00 |
% |
|
| SCHEDULE OF STOCK BASED EXPENSE FOR STOCK OPTION |
SCHEDULE
OF STOCK BASED EXPENSE FOR STOCK OPTION
| |
|
January 31,
2025
|
|
|
January 31, 2024
|
|
|
January 31, 2025
|
|
|
January 31, 2024
|
|
| |
|
Three Months Ended |
|
|
Nine Months Ended |
|
| |
|
January 31,
2025
|
|
|
January 31, 2024
|
|
|
January 31, 2025
|
|
|
January 31, 2024
|
|
| Compensation and related taxes – general and administrative |
|
$ |
423,106 |
|
|
$ |
7,402 |
|
|
$ |
437,910 |
|
|
$ |
22,206 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Professional and consulting fees |
|
|
574,390 |
|
|
|
- |
|
|
|
574,390 |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total |
|
$ |
997,496 |
|
|
$ |
7,402 |
|
|
$ |
1,012,300 |
|
|
$ |
22,206 |
|
|
| SCHEDULE OF STOCK WARRANT ACTIVITY |
A
summary of the Company’s outstanding warrants to purchase shares of common stock as of January 31, 2025, and the changes during
the period are presented below:
SCHEDULE
OF STOCK WARRANT ACTIVITY
| |
|
Number of Warrants |
|
|
Weighted
Average
Exercise Price
|
|
|
Weighted Average Remaining
Contractual
Life (Years)
|
|
| Warrants with no Class designation: |
|
|
|
|
|
|
|
|
|
|
|
|
| Balance at April 30, 2024 |
|
|
4,179,262 |
|
|
$ |
6.66 |
|
|
|
4.01 |
|
| Granted |
|
|
728,850 |
|
|
|
9.50 |
|
|
|
— |
|
| Exercised |
|
|
(120,000 |
) |
|
|
4.80 |
|
|
|
— |
|
| Forfeited |
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Canceled |
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Balance at January 31, 2025 |
|
|
4,788,112 |
|
|
|
7.14 |
|
|
|
3.17 |
|
| Class A Warrants: |
|
|
|
|
|
|
|
|
|
|
|
|
| Balance at April 30, 2024 |
|
|
109,687 |
|
|
|
11.40 |
|
|
|
0.64 |
|
| Granted |
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Exercised |
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Forfeited |
|
|
(109,687 |
) |
|
|
— |
|
|
|
— |
|
| Canceled |
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Balance at January 31, 2025 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Total Warrants Outstanding at January 31, 2025 |
|
|
4,788,112 |
|
|
$ |
7.14 |
|
|
|
3.17 |
|
| Warrants exercisable at end of period |
|
|
4,059,262 |
|
|
$ |
6.72 |
|
|
|
3.23 |
|
| Weighted average fair value of warrants granted during the period |
|
|
|
|
|
$ |
9.50 |
|
|
|
|
|
|